🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Response and Content Removal

According to TikTok, the platform has taken down violative content and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, glowing testimonials and detailed guides for preparing or administering at residence.

Within moments of joining one community, a seller shared WhatsApp details, where most purchases occur. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.

Product Information and Costs

Inside these communities, posts show black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to potentially serious health risks”.